Previous close | 21.95 |
Open | 21.35 |
Bid | 45.45 |
Ask | 46.70 |
Strike | 275.00 |
Expiry date | 2024-10-18 |
Day's range | 46.44 - 46.44 |
Contract range | N/A |
Volume | |
Open interest | 73 |
Competition is heating up in the GLP-1 space as Amgen gets closer to the finish line with its candidate.
Insightful Analysis of Amgen Inc's Strengths, Weaknesses, Opportunities, and Threats
Apple reports better-than-estimated earnings and expands its buyback program by $110 billion, Amgen ‘very encouraged’ by preliminary data from a trial of a weight-loss drug, and Expedia reduces its sales outlook for the year.